Status:
WITHDRAWN
A Pilot Randomized Controlled Trial for Antibiotic Exposure in Neonatal Sepsis Using Neutrophil CD64
Lead Sponsor:
Yale University
Conditions:
Neonatal Early-onset Sepsis
Neonatal Late-onset Sepsis
Eligibility:
All Genders
1-5 years
Phase:
NA
Brief Summary
Unnecessary and prolonged antibiotic therapy in newborn babies can have serious consequences including development of necrotizing enterocolitis (a serious, potentially life-threatening gastrointestina...
Eligibility Criteria
Inclusion
- Infants undergoing a sepsis evaluation in the NICU
Exclusion
- They have a major life-threatening congenital malformation
- The attending neonatologist has objections to the infant participating in the study
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01825421
Start Date
October 1 2014
End Date
June 1 2016
Last Update
March 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale-New Haven Children's Hospital NICU
New Haven, Connecticut, United States, 06520